104 related articles for article (PubMed ID: 16265556)
1. Does carvedilol have antiarrhythmic properties?
Naccarelli GV
Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):338-9. PubMed ID: 16265556
[No Abstract] [Full Text] [Related]
2. Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial.
McMurray J; Køber L; Robertson M; Dargie H; Colucci W; Lopez-Sendon J; Remme W; Sharpe DN; Ford I
J Am Coll Cardiol; 2005 Feb; 45(4):525-30. PubMed ID: 15708698
[TBL] [Abstract][Full Text] [Related]
3. Carvedilol saves lives--new data from landmark trials prove survival benefits in heart failure and post myocardial infarction.
Cardiovasc J S Afr; 2001; 12(2):122-3. PubMed ID: 11474697
[No Abstract] [Full Text] [Related]
4. Randomized active-controlled study comparing effects of treatment with carvedilol versus metoprolol in patients with left ventricular dysfunction after acute myocardial infarction.
Mrdovic IB; Savic LZ; Perunicic JP; Asanin MR; Lasica RM; Jelena MM; Matic MD; Vasiljevic ZM; Ostojic MC
Am Heart J; 2007 Jul; 154(1):116-22. PubMed ID: 17584563
[TBL] [Abstract][Full Text] [Related]
5. [Antioxidant and antiarrhythmic activity of carvedilol in patients with ischemic heart disease. Comparison with anaprilin].
Vasil'ev AP; Strel'tsova NN; Gorbunova TIu; Mal'tseva IA; Zykova EL
Ter Arkh; 2001; 73(10):65-7. PubMed ID: 11763521
[TBL] [Abstract][Full Text] [Related]
6. Beta-blockers and ventricular arrhythmias in dilated cardiomyopathy.
Fauchier L; Giraudeau B
J Am Coll Cardiol; 2000 Jun; 35(7):1993-4. PubMed ID: 10841254
[No Abstract] [Full Text] [Related]
7. Design and methodology of the CAPRICORN trial - a randomised double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction.
Dargie HJ
Eur J Heart Fail; 2000 Sep; 2(3):325-32. PubMed ID: 10938495
[No Abstract] [Full Text] [Related]
8. [Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial].
Costalunga A; Gavazzi A
Ital Heart J Suppl; 2001 Nov; 2(11):1246-7. PubMed ID: 11775420
[No Abstract] [Full Text] [Related]
9. Effect of beta blockers, particularly carvedilol, on reducing the risk of events after acute myocardial infarction.
Kopecky SL
Am J Cardiol; 2006 Oct; 98(8):1115-9. PubMed ID: 17027583
[TBL] [Abstract][Full Text] [Related]
10. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.
Dargie HJ
Lancet; 2001 May; 357(9266):1385-90. PubMed ID: 11356434
[TBL] [Abstract][Full Text] [Related]
11. Carvedilol following AMI.
Herner SJ; Seaton TL
J Fam Pract; 1997 Oct; 45(4):288-9. PubMed ID: 9379146
[No Abstract] [Full Text] [Related]
12. Landmark study: the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction Study (CAPRICORN).
Colucci WS
Am J Cardiol; 2004 May; 93(9A):13B-6B. PubMed ID: 15144931
[TBL] [Abstract][Full Text] [Related]
13. Carvedilol: use in chronic heart failure.
Doughty RN; White HD
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
[TBL] [Abstract][Full Text] [Related]
14. New evidence from the CAPRICORN Trial: the role of carvedilol in high-risk, post-myocardial infarction patients.
Sackner-Bernstein JD
Rev Cardiovasc Med; 2003; 4 Suppl 3():S25-9. PubMed ID: 14564231
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic profile of controlled-release carvedilol in patients with left ventricular dysfunction associated with chronic heart failure or after myocardial infarction.
Packer M; Lukas MA; Tenero DM; Baidoo CA; Greenberg BH;
Am J Cardiol; 2006 Oct; 98(7A):39L-45L. PubMed ID: 17023231
[TBL] [Abstract][Full Text] [Related]
16. [Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].
Kanopskiĭ SG; Staritskiĭ AG; Bozhko AA
Kardiologiia; 2004; 44(10):13-8. PubMed ID: 15477784
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
Wali RK; Iyengar M; Beck GJ; Chartyan DM; Chonchol M; Lukas MA; Cooper C; Himmelfarb J; Weir MR; Berl T; Henrich WL; Cheung AK
Circ Heart Fail; 2011 Jan; 4(1):18-26. PubMed ID: 21036889
[TBL] [Abstract][Full Text] [Related]
18. Switching to once-daily evidence-based [beta]-blockers in patients with systolic heart failure or left ventricular dysfunction after myocardial infarction.
Albert NM
Crit Care Nurse; 2007 Dec; 27(6):62-72. PubMed ID: 18032686
[No Abstract] [Full Text] [Related]
19. Carvedilol--a wide therapeutic potential in cardiovascular syndromes. Introduction.
Taylor SH; Storstein L
Cardiology; 1993; 82 Suppl 3():1-2. PubMed ID: 8106157
[No Abstract] [Full Text] [Related]
20. [Effect of carvedilol on parameters of myocardial perfusion in patients with left ventricular remodeling after myocardial infarction].
Kardiologiia; 2009; 49(2):66. PubMed ID: 19254220
[No Abstract] [Full Text] [Related]
[Next] [New Search]
